Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekznCfbwocfCeWnhtTLQ

  ADVERTISEMENT  
February 19, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
  • Could manufactured platelets help heal wounds?
    Artificial platelets, made of biomaterial mimicking the human platelet in blood, could be used to stop bleeding and help seal wounds, researchers said at an annual meeting of the American Association for the Advancement of Science. Scientists suggest the materials could be freeze-dried and injected into wounded soldiers during battle. Researchers found that the artificial platelets reduced clotting time by 30% and blood loss by up to 40%. MyHealthNewsDaily.com (2/15) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Patient Blood Management Resources from AABB
AABB offers a host of tools for transfusion decision makers. Clinical guidelines, education sessions and more. AABB Members can download Getting Started in Patient Blood Management and Citations in Patient Blood Management for FREE. Visit aabb.org/pbm for more information.

  Science & Health 
  Emerging Trends 
  • Spectroscopy method detects fake malaria-fighting tablets
    Researchers from the U.K. said a method related to NMR spectroscopy, known as nuclear quadrupole resonance spectroscopy, can be an effective way to detect fake drugs. Researchers used the technique to detect fake Metakelfin, an antimalarial drug, finding that the counterfeit tablets contained only 43% of the necessary amount of sulfalene. Researchers hope the method can be modified to identify other counterfeit drugs and harnessed for the development of a portable fake-drug detector. The findings were published in the journal Analytical Chemistry. Chemical & Engineering News (2/18) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • More than half of U.S. patients live in ACO areas
    Fifty-two percent of U.S. patients reside in regions served by accountable care organizations, up from 45% in August, data from an Oliver Wyman analysis show. Researchers also found 28% or more of patients live in areas with at least two ACOs, an increase from 17% in August. BeckersHospitalReview.com (2/18) LinkedInFacebookTwitterEmail this Story
The Buzz(CORPORATE ANNOUNCEMENTS)

Registration Now Open - April 9, 2013 PACT Workshop
“Developing Cellular Therapies: From Preclinical Safety to Clinical Evaluation”. Hosted by University of Wisconsin, Waisman Biomanufacturing (WB), Madison, WI. No charge for attendance. Click here for more details.


  Government & Regulatory 
  • CMS proposes MLR requirements for Medicare Advantage, Part D
    A CMS rule proposed Friday lays out medical loss ratio requirements for Medicare plans under the Affordable Care Act. Medicare Part D and Medicare Advantage plans must spend 85% of revenue on quality improvements, prescription drugs, clinical services and other clear patient benefits, the CMS said. Plans that fail to meet the requirements would see enrollment sanctions after three years in a row, and contracts would be terminated after failing to meet requirements for five consecutive years. MedPage Today (free registration) (2/18), PharmaTimes (U.K.) (2/18) LinkedInFacebookTwitterEmail this Story
  • Medicare changes are still possible, top Democrat says
    The House Budget Committee's Rep. Chris Van Hollen, D-Md., said he might back the proposed union of Medicare Parts A and B to reduce waste in the federal programs. Despite being wary of a plan that could include cuts, Van Hollen said he "would not say 'no' off the cuff to that kind of idea." The Hill/Healthwatch blog (2/15) LinkedInFacebookTwitterEmail this Story
  Association News 
  • AABB posts new and updated emerging infectious disease fact sheets
    The AABB Transfusion Transmitted Diseases Committee has created a new emerging infectious disease fact sheet for human parvovirus PARV4 and has updated the existing fact sheet for human parvovirus B19. The new fact sheet for the recently identified PARV4 disease agent (3 genotypes) includes a description of the bocaviruses, or HBoV (4 genotypes), another newly discovered human parvovirus. Both fact sheets are available on AABB's EID Web page. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Supervisor of Blood Donor ServicesBaystate HealthUS - MA - Springfield
Donor Collections DirectorBlood Centers of the PacificUS - CA - San Francisco
Medical Technologist CLS - Cord Blood ProgramSan Diego Blood BankUS - CA - San Diego
Click here to view more job listings.

  SmartQuote 
Everything that lives, lives not alone, nor for itself."
--William Blake,
British poet and painter


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information